DeuterOncology
PrivateLast Round
Grant
Apr 7, 2023
Total Funding Raised
$12.72M
Company Overview
DeuterOncology is a biotechnology company developing a deuterated MET kinase inhibitor as a targeted therapy for MET driven diseases, such as lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeuterOncology Comparables
Compare DeuterOncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 76% | |
| HUTCHMED (China) Limited | 74% | |
| Merck | 73% | |
DeuterOncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 7, 2023 | ||||
| Series A | Jan 19, 2023 | ||||
| Series A | Jan 19, 2023 | ||||
| Seed | Feb 24, 2021 |
Key People
Founding team and executive leadership
DeuterOncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public service of Wallonia | Grant |
| Newton Biocapital | Series A, Seed |
| Noshaq | Series A |
| Financière Spin-off Luxembourgeoise | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Monthly visitors increased 677% MoM.
- Apr 7, 2023
$515K grant received from Public service of Wallonia.
DeuterOncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DeuterOncology's valuation, stock price, and market status.